Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Gait & Posture|November 3, 2017
Age-associated changes in obstacle negotiation strategies: Does size and timing matter?I Maidan, S Eyal, I Kurz, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2001
Freezing of gait in patients with advanced Parkinson's diseaseN Giladi, T A Treves, E S Simon, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
Globus pallidus internus pallidotomy for generalized dystoniaA M Lozano, R Kumar, R E Gross, et al.Parkinsonism & Related Disorders|September 14, 2020
Which obstacle attributes place additional demands on higher-level cognitive function in patients with Parkinson's disease?T Sharon, I Kurz, H Bernad-Elazari, et al.Clinical Neuropharmacology|September 29, 2001
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopaJ M Rabey, I Sagi, M Huberman, et al.Neurology|October 17, 2007
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?A Orr-Urtreger, C Shifrin, U Rozovski, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 5, 2002
Clinical characteristics of neuroleptic-induced parkinsonismS Hassin-Baer, P Sirota, A D Korczyn, et al.Journal of Neurology|August 3, 2015
The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson diseaseZ Gan-Or, I Amshalom, A Bar-Shira, et al.Experimental Gerontology|August 27, 2019
A new approach to quantifying the EEG during walking: Initial evidence of gait related potentials and their changes with aging and dual taskingI Maidan, D Patashov, S Shustak, et al.Stereotactic and Functional Neurosurgery|October 16, 2002
Targeting the subthalamic nucleusT Z Aziz, D Nandi, S Parkin, et al.Pageof 11